Skip to main content
. 2019 Jun 4;21(12):2676–2680. doi: 10.1038/s41436-019-0558-2

Fig. 1.

Fig. 1

Reporting of race in genome/exome sequencing (GS/ES) studies. a The percent of studies reporting age, gender, race, and ethnicity as a demographic variable. b The number of patients included in all studies as identified by race. c,d The number of c White and d Black patients with published sequencing data. The number of patients with existing data is shown in dark blue and the number of additional patients needed to sequence to reach 90% power to detect a pathogenic variant present in 10% of patients is shown in light blue. NHL non-Hodgkin lymphoma.